The National Biosafety Authority (NBA) will on Monday unveil its 2023-2027 Strategic Plan that seeks to propel it towards the attainment of its mission of facilitating safe development, transfer, handling, and use of genetically modified organisms (GMOs) in the Country.
The exercise will be presided over by Principal Secretary, State Department for Agriculture Dr. Paul Ronoh in Nairobi.
The Strategic Plan serves as a framework for achieving strategic goals through optimal utilization of available resources at the Authority and aligns its functions with the government’s Medium-Term Expenditure Framework (MTEF), Bottom-up Economic Transformation Agenda (BETA) and MTP IV (2023 -2027).
“The Plan is also a reflection of the Authority’s commitment to safeguarding human and animal health, protecting the environment, and fostering responsible innovation in modern biotechnology and this will be achieved through strategic objectives across eight Key Result Areas (KRAs), each supported by targeted strategies to guide the its efforts over the next five years,” said NBA acting Chief Executive Officer Nehemiah Ngetich.
In line with its mandate, the Authority has identified eight Key Result Areas (KRAs) in the plan which is: public awareness and education on biosafety, dynamic laws and institutional policies on biosafety; biosafety assessments; compliance and enforcement; biosafety information management; international partnerships and collaborative engagement in the implementation of the protocol and the CBD; infrastructural and operational efficiency; and human resource management.
“The Strategic Plan also, outlines the strategic objectives and strategic of the Authority to be implemented over the period. Monitoring and evaluation of the SP will be done through; quarterly Reports; annual reports, Mid-term Evaluation and End-term Evaluation,” added Ngetich.
Muraya Kamunde
